103 related articles for article (PubMed ID: 16204938)
21. Chotosan ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia via activating the Nrf2-mediated antioxidant pathway.
Jiang P; Chen L; Sun J; Li J; Xu J; Liu W; Feng F; Qu W
J Pharmacol Sci; 2019 Feb; 139(2):105-111. PubMed ID: 30642751
[TBL] [Abstract][Full Text] [Related]
22. Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment.
Jin CH; Shin EJ; Park JB; Jang CG; Li Z; Kim MS; Koo KH; Yoon HJ; Park SJ; Choi WC; Yamada K; Nabeshima T; Kim HC
J Neurosci Res; 2009 Dec; 87(16):3658-70. PubMed ID: 19533734
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of Choto-san and hooks and stems of Uncaria sinensis against delayed neuronal death after transient forebrain ischemia in gerbil.
Yokoyama K; Shimada Y; Hori E; Sekiya N; Goto H; Sakakibara I; Nishijo H; Terasawa K
Phytomedicine; 2004 Sep; 11(6):478-89. PubMed ID: 15500258
[TBL] [Abstract][Full Text] [Related]
24. Effect of muscarinic cholinergic drugs on ischemia-induced decreases in glucose uptake and CA1 field potentials in rat hippocampus slices.
Shibata S; Kodama K; Tominaga K; Tanaka T; Watanabe S
Eur J Pharmacol; 1992 Oct; 221(1):113-9. PubMed ID: 1459186
[TBL] [Abstract][Full Text] [Related]
25. Rivastigmine improves isolation rearing-induced prepulse inhibition deficits via muscarinic acetylcholine receptors in mice.
Higashino K; Ago Y; Umeki T; Hasebe S; Onaka Y; Hashimoto H; Takuma K; Matsuda T
Psychopharmacology (Berl); 2016 Feb; 233(3):521-8. PubMed ID: 26518025
[TBL] [Abstract][Full Text] [Related]
26. Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
Egashira N; Manome N; Kurauchi K; Matsumoto Y; Iwasaki K; Mishima K; Shoyama Y; Fujiwara M
Phytother Res; 2007 Feb; 21(2):126-9. PubMed ID: 17117451
[TBL] [Abstract][Full Text] [Related]
27. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice.
Anagnostaras SG; Murphy GG; Hamilton SE; Mitchell SL; Rahnama NP; Nathanson NM; Silva AJ
Nat Neurosci; 2003 Jan; 6(1):51-8. PubMed ID: 12483218
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection by chotosan, a Kampo formula, against glutamate excitotoxicity involves the inhibition of GluN2B-, but not GluN2A-containing NMDA receptor-mediated responses in primary cultured cortical neurons.
Sasaki-Hamada S; Suzuki A; Sanai E; Matsumoto K; Oka JI
J Pharmacol Sci; 2017 Nov; 135(3):134-137. PubMed ID: 29146480
[TBL] [Abstract][Full Text] [Related]
29. Effect of propentofylline on ischemia-induced loss of muscarinic cholinergic receptor binding in the gerbil hippocampus.
Hirata H; Ogawa N; Haba K; Asanuma M; Chou H; Mori A
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):365-8. PubMed ID: 1509204
[TBL] [Abstract][Full Text] [Related]
30. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster FP; Heath I; Hendrix JC; Shannon HE
J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
[TBL] [Abstract][Full Text] [Related]
31. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
[TBL] [Abstract][Full Text] [Related]
32. Endogenous acetylcholine rescues NMDA-induced long-lasting hippocampal cell damage via stimulation of muscarinic M(1) receptors: elucidation using organic hippocampal slice cultures.
Inada C; Thi Le X; Tsuneyama K; Fujiwara H; Miyata T; Matsumoto K
Eur J Pharmacol; 2013 Jan; 699(1-3):150-9. PubMed ID: 23220711
[TBL] [Abstract][Full Text] [Related]
33. Tokishakuyakusan ameliorates spatial memory deficits induced by ovariectomy combined with β-amyloid in rats.
Egashira N; Akiyoshi Y; Iba H; Arai T; Hatip-Al-Khatib I; Mishima K; Iwasaki K
J Pharmacol Sci; 2018 Mar; 136(3):149-154. PubMed ID: 29478713
[TBL] [Abstract][Full Text] [Related]
34. Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.
Tanaka K; Yagi T; Shimakoshi R; Azuma K; Nanba T; Ogo H; Tamura A; Asanuma M
Neurosci Lett; 2009 Oct; 462(3):235-8. PubMed ID: 19615429
[TBL] [Abstract][Full Text] [Related]
35. [Effect of lidocaine on the impairment of learning and memory function and central cholinergic system after transient global cerebral ischemia in mice].
Song PP; Wang DX; Wang PY; Zuo PP
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):164-9. PubMed ID: 16617359
[TBL] [Abstract][Full Text] [Related]
36. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772
[TBL] [Abstract][Full Text] [Related]
37. Residential maze as a task for testing rats' maze learning ability: effects of hippocampal lesions and cholinergic receptor antagonists.
Yamada K; Kawai H; Iwasaki T; Ichitani Y
Neuroreport; 2002 Oct; 13(14):1759-64. PubMed ID: 12395118
[TBL] [Abstract][Full Text] [Related]
38. Muscarinic M1 acetylcholine receptors regulate the non-quantal release of acetylcholine in the rat neuromuscular junction via NO-dependent mechanism.
Malomouzh AI; Mukhtarov MR; Nikolsky EE; Vyskočil F
J Neurochem; 2007 Sep; 102(6):2110-2117. PubMed ID: 17561934
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia.
Wan L; Cheng Y; Luo Z; Guo H; Zhao W; Gu Q; Yang X; Xu J; Bei W; Guo J
J Ethnopharmacol; 2015 May; 165():118-26. PubMed ID: 25704930
[TBL] [Abstract][Full Text] [Related]
40. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety.
File SE; Kenny PJ; Cheeta S
Pharmacol Biochem Behav; 2000 May; 66(1):65-72. PubMed ID: 10837844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
